about
Genetics and genomics of radiotherapy toxicity: towards predictionExploiting biological and physical determinants of radiotherapy toxicity to individualize treatmentImaging tumour hypoxia with positron emission tomographyDynamic contrast-enhanced magnetic resonance imaging biomarkers in head and neck cancer: potential to guide treatment? A systematic reviewThe prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinomaIonizing radiation biomarkers in epidemiological studies - An update.Optimal design and patient selection for interventional trials using radiogenomic biomarkers: A REQUITE and Radiogenomics consortium statement.Radiogenomics: radiobiology enters the era of big data and team science.Exon array analysis of head and neck cancers identifies a hypoxia related splice variant of LAMA3 associated with a poor prognosisImproved accuracy and precision of tracer kinetic parameters by joint fitting to variable flip angle and dynamic contrast enhanced MRI data.Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.Exploiting sample variability to enhance multivariate analysis of microarray data.Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma.Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas.Photocytotoxic efficacy of sulphonated species of aluminium phthalocyanine against cell monolayers, multicellular spheroids and in vivo tumours.Lack of correlation between residual radiation-induced DNA damage, in keratinocytes assayed directly from skin, and late radiotherapy reactions in breast cancer patients.Enhancing fraction measured using dynamic contrast-enhanced MRI predicts disease-free survival in patients with carcinoma of the cervix.Expression of hypoxia-inducible factor-1α predicts benefit from hypoxia modification in invasive bladder cancerEpigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter.Establishment of a Radiogenomics Consortium.Lysyl oxidase: from basic science to future cancer treatment.A replicated association between polymorphisms near TNFα and risk for adverse reactions to radiotherapyIndividual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity.Computed tomography overestimation of esophageal tumor length: Implications for radiotherapy planning.The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosisMitochondrial DNA mutations in head and neck cancer are infrequent and lack prognostic utility.The potential of positron-emission tomography to study anticancer-drug resistance.FOXM1 and polo-like kinase 1 are co-ordinately overexpressed in patients with gastric adenocarcinomas.Statistical considerations of optimal study design for human plasma proteomics and biomarker discoveryMeasuring tumor pharmacodynamic response using PET proliferation probes: the case for 2-[(11)C]-thymidine.25th Paterson Symposium--is there a future for radiosensitivity testing?Stromal infiltration of CD8 T cells is associated with improved clinical outcome in HPV-positive oropharyngeal squamous carcinoma.Serum tumour markers in carcinoma of the uterine cervix and outcome following radiotherapyLevels of the DNA repair enzyme human apurinic/apyrimidinic endonuclease (APE1, APEX, Ref-1) are associated with the intrinsic radiosensitivity of cervical cancers.Enhanced stability of microRNA expression facilitates classification of FFPE tumour samples exhibiting near total mRNA degradation.Thoracic radiation therapy for limited-stage small-cell lung cancer: unanswered questions.Tissue factor expression in the metaplasia-adenoma-carcinoma sequence of gastric cancer in a European population.Is the hypoxia-inducible factor pathway important in gastric cancer?Imaging vascular physiology to monitor cancer treatment.The FOXM1-PLK1 axis is commonly upregulated in oesophageal adenocarcinoma.
P50
Q21183971-2079BC6F-8160-4A50-8937-31C4611DDF66Q26849735-82DEBECD-1503-4C0D-9E96-6B56FB2B6783Q26851422-53149A2D-B41C-4FEB-9635-A3FB47D5D6A3Q27008506-FB8F4E5A-F70F-4D93-ABF7-23A37D008937Q28296020-91C63E1D-150E-4C15-8B72-857E78F12333Q30235085-527DCC02-9BA9-4BB3-87AC-A2B11DCA6D9FQ30240052-E6079D61-0CBF-4573-9413-CF73E550E4CBQ30833608-4F5B2041-71D0-4BBC-A400-EAFB021BD70EQ30912245-8619A074-7F8D-480C-858E-506829A6FD06Q31007807-F8450754-4A9C-44A1-8986-102345BC032DQ31116483-26A28A12-DEF8-42A3-8E07-8AB63D7FB730Q31126696-D8267176-2FEA-47F3-80BA-2FC1A42153DFQ31926036-8A1B9CB1-DD0F-48D5-A8B8-070CEFE7E2CAQ33187096-7E8DA7F2-9693-4A3D-AAEC-67585656FAF4Q33421401-38408C61-E719-484D-B3E1-87CFEE0A0198Q33541467-5F835BBE-900C-4876-BDCB-8DDCB311B29FQ33620142-914A2356-B613-4696-8116-030DEBE9359AQ33994365-12F45B52-6F37-4A41-8134-3C66D761E95CQ34028615-CADC2425-D574-492F-9278-0D681BAE99B6Q34106703-154B3F64-99C8-46C6-B83C-C835257D29BBQ34263983-018153AD-F81B-47C2-9452-832DF93BE5C7Q34286293-6FE6FF7A-E3E3-47D7-9956-52E771568F8CQ34314677-9604AE2E-C8D2-4FC4-999C-FE0790A6E8BBQ34391197-6E564162-5503-48C7-B1E7-2947708212C4Q34745747-A054532F-00F1-4915-8B09-E5C4689C55B6Q34806878-DBA1E2AC-8B2C-44AB-9B80-B5CE331520DCQ35788120-B0D8AEFD-992E-4E08-8239-A29A7BDD66FCQ35843942-DFB49C43-B328-40E0-A126-64DD910EFD04Q35873957-16A8B9A9-C1FD-409D-ABA1-6CAA023010CCQ35978722-F7B84BC0-7916-43AB-B698-682B6170902FQ35992793-1ED3FB4E-00DF-4557-903F-227708439A5EQ36081369-61782897-7A38-4FAF-8F99-34DE4E37A111Q36081760-DC83F273-D2D7-4162-A2BB-E7CA39605E73Q36115019-ED6981AA-7E46-42E5-92CF-39555F4AB06AQ36166783-A7A1B0B0-0E97-4490-9F55-38971C5DF771Q36228172-92084041-B170-439D-8FC1-6D7C49D348B4Q36287981-72FCF135-ACE9-4453-897F-E9F262FF3751Q36313781-E9C8299B-0D90-462D-8BE9-D4119CB45005Q36357607-1C74CBFC-C070-4E1D-9B1D-D8F9B7CF28B8Q36385649-C1422C80-1BB0-4181-84E0-9290A28340A2
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Catharine M. West
@ast
Catharine M. West
@en
Catharine M. West
@es
Catharine M. West
@nl
Catharine M. West
@sl
type
label
Catharine M. West
@ast
Catharine M. West
@en
Catharine M. West
@es
Catharine M. West
@nl
Catharine M. West
@sl
altLabel
Catharine West
@en
prefLabel
Catharine M. West
@ast
Catharine M. West
@en
Catharine M. West
@es
Catharine M. West
@nl
Catharine M. West
@sl
P1153
P1053
J-4152-2012
P106
P1153
35480328200
57192044273
57198881207
P21
P31
P3829
P496
0000-0002-0839-3449